Oar Health Launches Clutch™, the First-Ever Fast-Acting Mint to Treat Alcohol Use Disorder

Audio By Carbonatix

NEW YORK--(BUSINESS WIRE)--Nov 12, 2025--

Oar Health, a virtual care platform offering access to medication for alcohol use disorder, today announced the launch of Clutch™, the first orally dissolvable mint formulation of naltrexone.

Naltrexone is a pharmaceutical ingredient proven to reduce alcohol cravings and heavy drinking. Clutch™ is a compounded formulation that delivers naltrexone sublingually, dissolving under the tongue in less than a minute.

Over seventy percent of Oar Health members join with the goal of moderating their drinking, not quitting entirely. As a fast-dissolving mint, Clutch™ may meet the individual needs of many of these patients, especially those seeking:

• To target naltrexone use, taking the medication shortly before drinking occasions, an increasingly popular approach.
• Fewer gastrointestinal side effects. Clutch™ bypasses first pass digestion because it is absorbed directly into the bloodstream.
• A discreet option. The mint format enables patients to take it confidently into real-world settings such as bars and restaurants.

Oar Health makes it easy to get access to Clutch™. People who are seeking to drink less or quit alcohol entirely complete an online consultation with a healthcare professional to receive their treatment plan and prescription for Clutch™, if it meets their individual needs. From there, Clutch™ will be delivered directly to their door within 2-3 days. Oar Health provides its members ongoing access to healthcare professionals and coaches, digital check-ins, and education, and community support to help members reach their goals.

“We are proud to offer Clutch™ as a new medication option,” said Jonathan Hunt-Glassman, Founder and CEO of Oar Health. “We have helped more than 50,000 people start treatment with traditional naltrexone tablets. While the classic formulation is a great option, we’ve learned that some of our members need a discreet option they can use in the moments when alcohol use is most difficult to avoid or control. Clutch™ is an innovation that meets those needs, empowering them to take back control over alcohol.”

Targeted use of naltrexone, also known as The Sinclair Method, where people take the medication shortly before a drinking occasion, is becoming increasingly recognized as an evidence-based protocol. Emerging evidence indicates it may be particularly helpful to binge drinkers. Journalist Katie Herzog’s recently published book Drink Your Way Sober, detailing her own success with The Sinclair Method, brought additional attention. Clutch™ now offers an option that better meets the needs of patients pursuing targeted use.

“The development of an orally dissolvable formulation of naltrexone represents the most important innovation in medications to treat alcohol use disorder in several decades,” said Dr. Dr. Joseph Volpicelli, MD, PhD, Executive Director, The Institute of Addiction Medicine, and Senior Adviser to Oar Health. “Only 2.5% of the 28 million Americans with alcohol use disorder get access to medication that can help them drink less or quit. Offering new, convenient medication options is an important way to close that gap.”

Launching Clutch™ continues Oar Health’s mission to build a world where no one hits rock bottom by providing convenient, private, effective, and judgment-free care. In addition to Clutch™, Oar Health members have access to generic naltrexone, ongoing clinical care, health coaching, self-guided check-ins, education and community support. Oar Health is the most used and most trusted provider of medication-assisted treatment for alcohol use disorder.

Clutch™ is a compound medication. Compounded drug products are prepared for individual patients based on a prescription from a licensed clinician. Compounded drug products are not reviewed by the FDA for safety or efficacy.

About Oar Health

Oar Health is a virtual care platform offering FDA-approved medication to help people drink less or quit. Built by a former patient and backed by pioneers in addiction medicine, Oar delivers a daily pill plus expert guidance. No judgment, just help. Learn more at www.oarhealth.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251112850345/en/

CONTACT: Media Contact:

Hanna Refvik

SolComms

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: MENTAL HEALTH FDA HEALTH TELEMEDICINE/VIRTUAL MEDICINE OTHER HEALTH PHARMACEUTICAL

SOURCE: Oar Health

Copyright Business Wire 2025.

PUB: 11/12/2025 09:00 AM/DISC: 11/12/2025 09:01 AM

http://www.businesswire.com/news/home/20251112850345/en